These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30043888)

  • 21. Risk factors for FEV
    Chen S; Wang C; Li B; Shi G; Li H; Zhang J; Gu Y; Zhou J; Song Y; Bai C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():435-442. PubMed ID: 28184155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An association between chronic obstructive pulmonary disease and abdominal aortic aneurysm beyond smoking: results from a case-control study.
    Meijer CA; Kokje VB; van Tongeren RB; Hamming JF; van Bockel JH; Möller GM; Lindeman JH
    Eur J Vasc Endovasc Surg; 2012 Aug; 44(2):153-7. PubMed ID: 22705161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
    Medbø A; Melbye H
    Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Male current smokers have low awareness and optimistic bias about COPD: field survey results about COPD in Korea.
    Hwang YI; Park YB; Yoon HK; Kim TH; Yoo KH; Rhee CK; Park JH; Jang SH; Park S; Kim JH; Park J; Jung KS
    Int J Chron Obstruct Pulmon Dis; 2019; 14():271-277. PubMed ID: 30718953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of acute deterioration in health status visit among COPD patients by monitoring COPD assessment test score.
    Pothirat C; Chaiwong W; Limsukon A; Deesomchok A; Liwsrisakun C; Bumroongkit C; Theerakittikul T; Phetsuk N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():277-82. PubMed ID: 25678783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VitalQPlus: a potential screening tool for early diagnosis of COPD.
    Sui CF; Ming LC; Neoh CF; Ibrahim B
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1613-22. PubMed ID: 26316735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural Predictors of Lung Function Decline in Young Smokers with Normal Spirometry.
    Ritchie AI; Donaldson GC; Hoffman EA; Allinson JP; Bloom CI; Bolton CE; Choudhury G; Gerard SE; Guo J; Alves-Moreira L; McGarvey L; Sapey E; Stockley RA; Yip KP; Singh D; Wilkinson T; Fageras M; Ostridge K; Jöns O; Bucchioni E; Compton CH; Jones P; Mezzi K; Vestbo J; Calverley PMA; Wedzicha JA;
    Am J Respir Crit Care Med; 2024 May; 209(10):1208-1218. PubMed ID: 38175920
    [No Abstract]   [Full Text] [Related]  

  • 28. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of colorectal adenomatous polyps in patients with chronic obstructive pulmonary disease.
    Chun EM; Kim SW; Lim SY
    Int J Chron Obstruct Pulmon Dis; 2015; 10():955-60. PubMed ID: 26028968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Components of the COPD Assessment Test (CAT) associated with a diagnosis of COPD in a random population sample.
    Raghavan N; Lam YM; Webb KA; Guenette JA; Amornputtisathaporn N; Raghavan R; Tan WC; Bourbeau J; O'Donnell DE
    COPD; 2012 Apr; 9(2):175-83. PubMed ID: 22409441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening Heroin Smokers Attending Community Drug Clinics for Change in Lung Function: A Cohort Study.
    Nightingale R; Mortimer K; Giorgi E; Walker PP; Stolbrink M; Byrne T; Marwood K; Morrison-Griffiths S; Renwick S; Rylance J; Burhan H
    Chest; 2020 Mar; 157(3):558-565. PubMed ID: 31759961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence, risk factors, and health-related quality of life of osteoporosis in patients with COPD at a community hospital in Taiwan.
    Lin CW; Chen YY; Chen YJ; Liang CY; Lin MS; Chen W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1493-500. PubMed ID: 26251589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Screening Study to Determine the Prevalence of Airway Disease in Heroin Smokers.
    Lewis-Burke N; Vlies B; Wooding O; Davies L; Walker PP
    COPD; 2016 Jun; 13(3):333-8. PubMed ID: 26701201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence and characteristics of chronic obstructive pulmonary disease in non-smokers].
    Montserrat-Capdevila J; Godoy P; Marsal JR; Ortega M; Barbé F; Castañ MT; Seminario MA; Pujol J; Alsedà M
    Aten Primaria; 2019 Dec; 51(10):602-609. PubMed ID: 30454958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study.
    van Gemert F; Kirenga B; Chavannes N; Kamya M; Luzige S; Musinguzi P; Turyagaruka J; Jones R; Tsiligianni I; Williams S; de Jong C; van der Molen T
    Lancet Glob Health; 2015 Jan; 3(1):e44-51. PubMed ID: 25539969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study.
    Thomsen M; Nordestgaard BG; Vestbo J; Lange P
    Lancet Respir Med; 2013 Sep; 1(7):543-50. PubMed ID: 24461615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a simple screening tool for opportunistic COPD case finding in primary care in Latin America: The PUMA study.
    López Varela MV; Montes de Oca M; Rey A; Casas A; Stirbulov R; Di Boscio V;
    Respirology; 2016 Oct; 21(7):1227-34. PubMed ID: 27319305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COPD assessment test as a possible tool for evaluating health-related quality of life in lymphangioleiomyomatosis.
    Kato M; Kanehiro Y; Yoshimi K; Kodama Y; Sekiya M; Sato T; Takahashi K; Seyama K;
    Respir Investig; 2018 Nov; 56(6):480-488. PubMed ID: 30143460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using dynamics of forced expiration to identify COPD where conventional criteria for the FEV₁ /FVC ratio do not match.
    Topalovic M; Exadaktylos V; Decramer M; Berckmans D; Troosters T; Janssens W
    Respirology; 2015 Aug; 20(6):925-31. PubMed ID: 25880716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
    Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
    COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.